HLA-DRB1*0402 (DW10) transgene protects collagen-induced arthritis-susceptible H2Aq and DRB1*0401 (DW4) transgenic mice from arthritis

Journal of Immunology

Volumn 171, Issue 8, 2003, Pages 4431-4438

  Taneja, Veena ^a,d   Taneja, Neelam ^b   Behrens, Marshall ^a   Pan, Suchong ^a   Trejo, Tad ^a   Grifiiths, Marie ^c   Luthra, Harvinder ^a   David, Chella S ^a  

^a MAYO CLINIC   (United States)

^b UNIVERSITY OF CHICAGO   (United States)

^c UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^d MAYO GRADUATE SCHOOL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

COLLAGEN; COLLAGEN TYPE 2; CYTOKINE; H2 ANTIGEN; HLA DR ANTIGEN; HLA DR4 ANTIGEN; AUTOANTIBODY; AUTOANTIGEN; EPITOPE; H-2A ANTIGEN; HLA D ANTIGEN; HLA DW10; HLA DW4; HLA-DRB1 ANTIGEN; HLA-DW10; HLA-DW4; LYMPHOCYTE ANTIGEN RECEPTOR; PEPTIDE FRAGMENT;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTHRITIS; ARTICLE; AUTOIMMUNITY; CONTROLLED STUDY; CYTOKINE PRODUCTION; DISEASE COURSE; DISEASE PREDISPOSITION; GENETIC POLYMORPHISM; IMMUNIZATION; IN VITRO STUDY; IN VIVO STUDY; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH2 CELL; THYMUS; TRANSGENE; TRANSGENIC MOUSE; ANIMAL; ANTIBODY SPECIFICITY; BIOSYNTHESIS; C57BL MOUSE; CATTLE; GENE DELETION; GENETIC PREDISPOSITION; GENETICS; HUMAN; IMMUNOLOGICAL TOLERANCE; IMMUNOLOGY; PATHOLOGY; PHYSIOLOGY; SWINE;

ANIMALS; ANTIBODY SPECIFICITY; APOPTOSIS; ARTHRITIS, EXPERIMENTAL; AUTOANTIBODIES; AUTOANTIGENS; CATTLE; COLLAGEN TYPE II; EPITOPES; GENE DELETION; GENETIC PREDISPOSITION TO DISEASE; H-2 ANTIGENS; HLA-D ANTIGENS; HLA-DR ANTIGENS; HUMANS; MICE; MICE, INBRED C57BL; MICE, TRANSGENIC; PEPTIDE FRAGMENTS; RECEPTORS, ANTIGEN, T-CELL, ALPHA-BETA; SELF TOLERANCE; SWINE; TRANSGENES;

EID: 0141923666     PISSN: 00221767     EISSN: None     Source Type: Journal    
DOI: 10.4049/jimmunol.171.8.4431     Document Type: Article

References (51)

1. Todd, J. A., J. I. Bell, and H. O. McDevitt. 1987. HLA-DQB gene contributes to susceptibility and resistance to insulin-dependent diabetes mellitus. Nature 329:599.
2. Nelson, J. L., and J. A. Hansen. 1990. Autoimmune diseases and HLA. Crit. Rev. Immunol. 10:307.
3. Ebers, G. C., and D. A. Dyment. 1998. Genetics of multiple sclerosis. Semin. Neurol. 18:295.
4. Wakeland, E. K., A. E. Wandstrat, K. Liu, and L. Morel. 1999. Genetic dissection of systemic lupus erythematosus. Curr. Opin. Immunol. 11:701.
5. Stastny, P. 1978. Association of the B-cell alloantigen DRw4 with rheumatoid arthritis. N. Engl. J. Med. 298:869.
6. Nepom. G. T. 1989. Determinants of genetic susceptibility in HLA-associated autoimmune disease. Clin. Immunol. Immunopathol. 53:S53.
7. Wordsworth, B. P., J. S. Lanchbury, L. I. Sakkas, K. I. Welsh, G. S. Panayi, and J. I. Bell. 1989. HLA-DR4 subtype frequencies in rheumatoid arthritis indicate that DRB1 is the major susceptibility locus within the HLA class 11 region. Proc. Natl. Acad. Sci. USA 86:10049.
8. Goldstein, R., and F. C. Arnett. 1987. The genetics of rheumatic disease in man. Rheum. Dis. Clin. N. Am. 13:587.
9. Taneja, V., M. J. Giphart, W. Verduijn, A. Naipal, A. N. Malaviya, and N. K. Mehra. 1996. Polymorphism of HLA-DRB, -DQA1, and -DQB1 in rheumatoid arthritis in Asian Indians: association with DRB1*0405 and DRB1*1001. Hum. Immunol. 46:35.
10. Yelamos, J., J. R. Garcia-Lozano, I. Moreno, I. Aguilera, M. F. Gonzalez, A. Garcia, A. Nunez-Roldan, and B. Sanchez. 1993. Association of HLA-DR4Dw15 (DRB1*0405) and DR10 with rheumatoid arthritis in a Spanish population. Arthritis Rheum. 36:811.
11. Wilkens, R. F., G. T. Nepom, C. R. Marks, J. W. Nettles, and B. S. Nepom. 1991. Association of HLA-DW16 with rheumatoid arthritis in Yakima Indians: further evidence for the shared epitope hypothesis. Arthritis Rheum. 34:43.
12. Gregersen, P. K., J. Silver, and R. J. Winchester. 1987. The shared epitope hypothesis: an approach to understanding the molecular genetics of susceptibility to rheumatoid arthritis. Arthritis Rheum. 30:1205.
13. Winchester, R. J., E. Dawyer, and S. Rose. 1992. The genetic basis of rheumatoid arthritis: the shared epitope hypothesis. Rheum. Dis. Clin. N. Am. 18:761.
14. Mitchison, N. A. 1992. Specialization, tolerance, memory, competition, latency, and strife among T cells. Annu. Rev. Immunol. 10:1.
15. Möller, E., J. Böhme, M. Abedi-Valugerdi, A. Ridderstad, and O. Olerup. 1990. Speculations on the mechanism of HLA association with autoimmune diseases and the specificity of autoreactive T lymphocytes. Immunol. Rev. 118:5.
16. Sattar, M. A., M. al-Saffar, R. T. Guindi, T. N. Sugathan, and K. Behbehani. 1990. Association between HLA-DR antigens and rheumatoid arthritis in Arabs. Ann. Rheum. Dis. 49:147.
17. Massardo, L., S. Jacobelli, L. Rodriguez, S. Rivero, A. Gonzalez, and R. Marchetti. 1990. Weak association between HLA-DR4 and rheumatoid arthritis in Chilean patients. Ann. Rheum. Dis. 49:290.
18. Terato, K., Y. Shimozuru, K. Katayama, Y. Takemitsu, I. Yamashita, M. Miyatsu, K. Fujii, M. Sagara, S. Kobayashi, M. Goto. et al. 1990. Specificity of antibodies to type II collagen in rheumatoid arthritis. Arthritis Rheum. 33:1493.
19. Eldayam, O., H. Zinger, E. Zisman, R. Segal, M. Yaron, C. Brautbar, and E. Mozes. 1991. Regulatory T cell activity specific to human type II and III collagens in rheumatoid arthritis. J. Rheumatol. 18:516.
20. He, X., A. H. Kang, and J. M. Stuart. 2000. Accumulation of T cells reactive to type II collagen in synovial fluid of patients with rheumatoid arthritis. J. Rheumatol. 27:589.
21. Nabozny, G. H., J. M. Baisch, S. Cheng, D. Cosgrove, M. M. Griffiths, H. S. Luthra, and C. S. David. 1996. HLA-DQ8 transgenic mice are highly susceptible to collagen-induced arthritis: a novel model for human polyarthritis. J. Exp. Med. 183:27.
22. Krco, C. J., J. Pawelski, J. Harders, D. McCormick, M. M. Griffiths, H. S. Luthra, and C. S. David. 1996. Characterization of the antigenic structure of human type 11 collagen. J. Immunol. 156:2761.
23. Taneja, V., and C. S. David. 1999. HLA class 11 transgenic mice as models of human diseases. Immunol. Rev. 169:67.
24. Zanelli, E., C. J. Krco, J. M. Baisch, S. Cheng, and C. S. David. 1996. Immune response of HLA-DQ8 transgenic mice to peptides from the third hypervariable region of HLA-DRB1 correlates with predisposition to rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 93:1814.
25. Kirschmann, D. A., K. L. Duffin, C. E. Smith, J. K. Welply, S. C. Howard, B. D. Schwartz, and S. L. Woulfe. 1995. Naturally processed peptides from rheumatoid arthritis associated and non-associated HLA-DR alleles. J. Immunol. 155:5655.
26. Snijders, A., D. G. Elferink, A. Geluk, A. L. van Der Zanden, K. Vos, G. M. Schreuder, F. C. Breedveld, R. R. de Vries, E. H. Zanetli. 2001. An HLA-DRB1-derived peptide associated with protection against rheumatoid arthritis is naturally processed by human APCs. J. Immunol. 166:4987.
27. Matsushita, S., T. Nishi, M. Oiso, K. Yamaoka, K. Yone, T. Kanai, and Y. Nishimura. 1996. HLA-DQ-binding motifs. I. Comparative binding analysis of type 11 collagen-derived peptides to DR and DQ molecules of rheumatoid arthritis-susceptible and non-susceptible haplotypes. Int. Immunol. 8:757.
28. Begovich, A. B., G. R. McClure, V. C. Suraj, R. C. Helmuth, N. Fildes, T. L. Bugawan, H. A. Erlich, and W. Klitz. 1992. Polymorphism recombination and linkage disequilibrium within the HLA class 11 region. J. Immunol. 148:249.
29. Taneja, V., N. K. Mehra, A. N. Chadreshekaran, R. K. Ahuja, Y. N. Singh, and A. N. Malaviya. 1992. HLA-DR4-DQw8 but not DR4-DQw7 haplotypes occur, in Indian patients with rheumatoid arthritis. Rheumatol. Int. 11:251.
30. Ilonen, J., H. Reijonen, H. Arvilommi, I. Jokinen, T. Mottonen, and P. Hannonen. 1990. HLA-DR antigens and HLA-DQβ chain polymorphism in susceptibility to rheumatoid arthritis. Ann. Rheum. Dis. 49:494.
31. Pan, S., V. Taneja, M. M. Griffiths, H. S. Luthra, and C. S. David. 1999. Complementation between HLA-DR4 (DRB1*0401) and specific H2-A molecule in transgenic mice leads to collagen-induced arthritis. Hum. Immunol. 60:816.
32. Pan, S., T. Trejo, J. Hansen, M. Smart, and C. S. David. 1998. HLA-DR4 (DRB1*0401) transgenic mice expressing an altered CD4-binding site: specificity and magnitude of DR4-restricted T cell response. J. Immunol. 161:2925.
33. Kouskoff, V., H. J. Fehling, M. Lemeur, C. Benoist. D. Mathis. 1993. A vector driving the expression of foreign cDNAs in the MHC class II-positive cells of transgenic mice. J. Immunol. Methods 166:287.
34. Taneja, V., N. Taneja, T. Paisansinsup, M. Behrens, M. M. Griffiths, H. Luthra, and C. S. David. 2002. CD4 and CD8 T Cells in susceptibility/protection to collagen-induced arthritis in HLA-DQ8 transgenic mice: implications for rheumatoid arthritis. J. Immunol. 168:5867.
35. Griffiths, M. M., E. J. Eichwald, J. H. Martin, C. B. Smith, and C. W. DeWitt. 1981. Immunogenetic control of experimental type II collagen induced arthritis. Arthritis Rheum. 24:781.
36. Wooley, P. H., H. S. Lthura, J. M. Stuart, and C. S. David. 1981. Type 11 collagen-induced arthritis in mice. I. Major histocompatibility complex (1 region) linkage and antibody correlates. J. Exp. Med. 154:688.
37. Griffiths, M. M., G. H. Nabozny, J. Hanson, J. S. Harper, S. McCall, K. G. Moder, G. W. Cannon, H. S. Luthra, and C. S. David. 1994. Collagen induced arthritis and TCRs in SWR and B10: Q mice expressing EaK transgene. J. Immunol. 153:2758.
38. Taneja, V., M. M. Griffiths, H. S. Luthra, and C. S. David. 1998. Modulation of HLA-DQ-restricted collagen-induced arthritis by HLA-DRB1 polymorphism. Int. Immunol. 10:1449.
39. Zanelli, E., M. A. Gonzalez-Gay, and C. S. David. 1995. Could DRB1 be the protective locus in rheumatoid arthritis? Immunol. Today 16:274.
40. Osman, G. E., M. C. Hannibal, J. P. Anderson, S. Cheunsuk, S. R. Lasky, H. D. Liggitt, W. C. Ladiges, and L. E. Hood. 1999. T cell receptor Vβ deletion and Vα polymorphism are responsible for the resistance of SWR mouse to arthritis induction. Immunogenetics 49:764.
41. Schmidt, D., J. Ver daguer, N. Averill, and P. Santamaria. 1997. A mechanism for the major histocompatibility complex-linked resistance to autoimmunity. J. Exp. Med. 186:1059.
42. Terato, K., K. A. Hasty, M. A. Cremer, J. M. Stuart, A. S. Towens, and A. H. Kang. 1985. Collagen induced arthritis in mice: localization of an arthritogenic determinant to a fragment of the type 11 collagen molecule. J. Exp. Med. 162:637.
43. Diab, B. Y., N. C. Lambert, F. E. L'Faqihi, P. Loubet-Lescoulie, C. de Preval, and H. Coppin. 1999. Human collagen 11 peptide 256-271 preferentially binds to HLA-DR molecules associated with susceptibility to rheumatoid arthritis. Immunogenetics 49:36.
44. Johansson, A. C., A. S. Hansson, K. S. Nandakumar, J. Backlund, and R. Holmdahl. 2001. IL-10-deficient B10, Q mice develop more severe collagen-induced arthritis, but are protected from arthritis induced with anti-type 11 collagen antibodies. J. Immunol. 167:3505.
45. Buer, J., A. Lanoue, A. Franzke, C. Garcia, H. von Bochmer, and A. Sarukhan. 1998. Interleukin 10 secretion and impaired effector function of major histocompatibility complex class II-restricted T cells anergized in vivo. J. Exp. Med. 187:177.
46. Rock, K. L., B. Benacerraf, and A. K. Abbas. 1984. Antigen presentation by hapten-specific B lymphocytes. I. Role of surface immunoglobulin receptors. J. Exp. Med. 160.1102.
47. Banda, N. K., A. Vondracek, D. Kraus, C. A. Dinarello, S. H. Kim, A. Bendele, G. Senaldi, and W. P. Arend. 2003. Mechanisms of inhibition of collagen-induced arthritis by murine IL-18 binding protein. J. Immunol. 170:2100.
48. Han, Z., D. L. Boyle, L. Chang, M. Karin, L. Yang, A. M. Manning, and G. S. Firestein. 2001. C-Jun N-terminal kinase is required for metalloproteinase expression and joint destruction in inflammatory arthritis. J. Clin. Invest. 108:73.
49. 2-terminal kinase in transformed B lymphoblasts. Nat. Genet. 32:201.
50. Londei, M., C. M. Savill, A. Verhoef, F. Brennan, Z. A. Leech, V. Duance, R. N. Maini, M. Feldmann. 1989. Persistence of collagen type II-specific T-cell clones in the synovial membrane of a patient with rheumatoid arthritis. Proc. Natl. Acad. Sci. USA 86:636.
51. + T cells in rheumatoid arthritis. J. Clin. Invest. 94:2068.